J9348 Injection. naxitamab-gqgk, 1 milligrams
Also known as: naxitamab, Qarziba
Injection of naxitamab-gqgk, 1 milligram. An anti-GD2 monoclonal antibody for neural crest-derived tumors.
In Plain Language
neuroblastoma injection; rare childhood cancer treatment
Clinical Context
Used for neuroblastoma with high GD2 expression. Immunotherapy inducing antibody-dependent cellular cytotoxicity against GD2-positive cells.
RVU Information
CPT J9348 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9348?
CPT J9348 (Injection. naxitamab-gqgk, 1 milligrams) is a J Codes (Drugs) code. Injection of naxitamab-gqgk, 1 milligram. An anti-GD2 monoclonal antibody for neural crest-derived tumors.
How is J9348 administered?
CPT J9348 is administered by a healthcare provider, typically via injection or infusion. Used for neuroblastoma with high GD2 expression. Immunotherapy inducing antibody-dependent cellular cytotoxicity against GD2-positive cells. It is used by Oncology, Pediatric Hematology, Pediatric Oncology.
When is CPT J9348 used?
Used for neuroblastoma with high GD2 expression. Immunotherapy inducing antibody-dependent cellular cytotoxicity against GD2-positive cells.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.